Eintrag weiter verarbeiten
Clinically useful flow cytometry approach to identify immunophenotype in acute leukemia
Gespeichert in:
| Zeitschriftentitel: | Journal of International Medical Research |
|---|---|
| Personen und Körperschaften: | , , , , , , , , , , , , , , |
| In: | Journal of International Medical Research, 47, 2019, 4, S. 1483-1492 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
SAGE Publications
|
| Schlagwörter: |
| author_facet |
Ouyang, Guifang Xu, Zhijuan Jiang, Danjie Zhu, Huiling Wang, Yi Wu, Wenmiao Sun, Yongcheng Sheng, Lixia Xu, Kaihong Lou, Yanru Mu, Qitian Zhang, Yi Wu, Ningning Cheng, Jia Duan, Shiwei Ouyang, Guifang Xu, Zhijuan Jiang, Danjie Zhu, Huiling Wang, Yi Wu, Wenmiao Sun, Yongcheng Sheng, Lixia Xu, Kaihong Lou, Yanru Mu, Qitian Zhang, Yi Wu, Ningning Cheng, Jia Duan, Shiwei |
|---|---|
| author |
Ouyang, Guifang Xu, Zhijuan Jiang, Danjie Zhu, Huiling Wang, Yi Wu, Wenmiao Sun, Yongcheng Sheng, Lixia Xu, Kaihong Lou, Yanru Mu, Qitian Zhang, Yi Wu, Ningning Cheng, Jia Duan, Shiwei |
| spellingShingle |
Ouyang, Guifang Xu, Zhijuan Jiang, Danjie Zhu, Huiling Wang, Yi Wu, Wenmiao Sun, Yongcheng Sheng, Lixia Xu, Kaihong Lou, Yanru Mu, Qitian Zhang, Yi Wu, Ningning Cheng, Jia Duan, Shiwei Journal of International Medical Research Clinically useful flow cytometry approach to identify immunophenotype in acute leukemia Biochemistry (medical) Cell Biology Biochemistry General Medicine |
| author_sort |
ouyang, guifang |
| spelling |
Ouyang, Guifang Xu, Zhijuan Jiang, Danjie Zhu, Huiling Wang, Yi Wu, Wenmiao Sun, Yongcheng Sheng, Lixia Xu, Kaihong Lou, Yanru Mu, Qitian Zhang, Yi Wu, Ningning Cheng, Jia Duan, Shiwei 0300-0605 1473-2300 SAGE Publications Biochemistry (medical) Cell Biology Biochemistry General Medicine http://dx.doi.org/10.1177/0300060518819637 <jats:sec><jats:title>Objectives</jats:title><jats:p> Acute leukemia (AL) is a highly heterogeneous malignant disease caused by hematopoietic cell abnormalities. Our study investigated the potential for immunophenotyping of leukemic cells via flow cytometry and the clinical usefulness of this approach in treatment of AL. </jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p> Bone marrow (BM) specimens were collected to detect antigen expression on hematopoietic cells in pre-treatment samples from patients with AL. In addition, fraction survival curves were calculated using the Kaplan-Meier method to explore the effect of markers on prognosis in AL. </jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p> Expression levels of immunophenotypic markers in patients with acute lymphoblastic leukemia (ALL) were significantly different from those in patients with acute myeloid leukemia (AML). In addition, there was a potential association between the surface marker, cluster of differentiation 2 (CD2), and fraction survival in AML. However, no similar result was found in ALL. Moreover, genetic tests showed greater positive variation of the break point cluster-Abelson tyrosine kinase ( BCR-ABL) fusion gene in samples from patients with ALL than in samples from patients with AML. </jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p> We have shown a rapid and effective flow cytometry method that enables the identification of immunophenotype in AL. Moreover, CD2 may constitute a predictive marker for prognosis in patients with AML. </jats:p></jats:sec> Clinically useful flow cytometry approach to identify immunophenotype in acute leukemia Journal of International Medical Research |
| doi_str_mv |
10.1177/0300060518819637 |
| facet_avail |
Online Free |
| finc_class_facet |
Biologie Chemie und Pharmazie |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE3Ny8wMzAwMDYwNTE4ODE5NjM3 |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE3Ny8wMzAwMDYwNTE4ODE5NjM3 |
| institution |
DE-Zwi2 DE-D161 DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 |
| imprint |
SAGE Publications, 2019 |
| imprint_str_mv |
SAGE Publications, 2019 |
| issn |
0300-0605 1473-2300 |
| issn_str_mv |
0300-0605 1473-2300 |
| language |
English |
| mega_collection |
SAGE Publications (CrossRef) |
| match_str |
ouyang2019clinicallyusefulflowcytometryapproachtoidentifyimmunophenotypeinacuteleukemia |
| publishDateSort |
2019 |
| publisher |
SAGE Publications |
| recordtype |
ai |
| record_format |
ai |
| series |
Journal of International Medical Research |
| source_id |
49 |
| title |
Clinically useful flow cytometry approach to identify immunophenotype in acute leukemia |
| title_unstemmed |
Clinically useful flow cytometry approach to identify immunophenotype in acute leukemia |
| title_full |
Clinically useful flow cytometry approach to identify immunophenotype in acute leukemia |
| title_fullStr |
Clinically useful flow cytometry approach to identify immunophenotype in acute leukemia |
| title_full_unstemmed |
Clinically useful flow cytometry approach to identify immunophenotype in acute leukemia |
| title_short |
Clinically useful flow cytometry approach to identify immunophenotype in acute leukemia |
| title_sort |
clinically useful flow cytometry approach to identify immunophenotype in acute leukemia |
| topic |
Biochemistry (medical) Cell Biology Biochemistry General Medicine |
| url |
http://dx.doi.org/10.1177/0300060518819637 |
| publishDate |
2019 |
| physical |
1483-1492 |
| description |
<jats:sec><jats:title>Objectives</jats:title><jats:p> Acute leukemia (AL) is a highly heterogeneous malignant disease caused by hematopoietic cell abnormalities. Our study investigated the potential for immunophenotyping of leukemic cells via flow cytometry and the clinical usefulness of this approach in treatment of AL. </jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p> Bone marrow (BM) specimens were collected to detect antigen expression on hematopoietic cells in pre-treatment samples from patients with AL. In addition, fraction survival curves were calculated using the Kaplan-Meier method to explore the effect of markers on prognosis in AL. </jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p> Expression levels of immunophenotypic markers in patients with acute lymphoblastic leukemia (ALL) were significantly different from those in patients with acute myeloid leukemia (AML). In addition, there was a potential association between the surface marker, cluster of differentiation 2 (CD2), and fraction survival in AML. However, no similar result was found in ALL. Moreover, genetic tests showed greater positive variation of the break point cluster-Abelson tyrosine kinase ( BCR-ABL) fusion gene in samples from patients with ALL than in samples from patients with AML. </jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p> We have shown a rapid and effective flow cytometry method that enables the identification of immunophenotype in AL. Moreover, CD2 may constitute a predictive marker for prognosis in patients with AML. </jats:p></jats:sec> |
| container_issue |
4 |
| container_start_page |
1483 |
| container_title |
Journal of International Medical Research |
| container_volume |
47 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792332905660284933 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T14:04:17.851Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Clinically+useful+flow+cytometry+approach+to+identify+immunophenotype+in+acute+leukemia&rft.date=2019-04-01&genre=article&issn=1473-2300&volume=47&issue=4&spage=1483&epage=1492&pages=1483-1492&jtitle=Journal+of+International+Medical+Research&atitle=Clinically+useful+flow+cytometry+approach+to+identify+immunophenotype+in+acute+leukemia&aulast=Duan&aufirst=Shiwei&rft_id=info%3Adoi%2F10.1177%2F0300060518819637&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792332905660284933 |
| author | Ouyang, Guifang, Xu, Zhijuan, Jiang, Danjie, Zhu, Huiling, Wang, Yi, Wu, Wenmiao, Sun, Yongcheng, Sheng, Lixia, Xu, Kaihong, Lou, Yanru, Mu, Qitian, Zhang, Yi, Wu, Ningning, Cheng, Jia, Duan, Shiwei |
| author_facet | Ouyang, Guifang, Xu, Zhijuan, Jiang, Danjie, Zhu, Huiling, Wang, Yi, Wu, Wenmiao, Sun, Yongcheng, Sheng, Lixia, Xu, Kaihong, Lou, Yanru, Mu, Qitian, Zhang, Yi, Wu, Ningning, Cheng, Jia, Duan, Shiwei, Ouyang, Guifang, Xu, Zhijuan, Jiang, Danjie, Zhu, Huiling, Wang, Yi, Wu, Wenmiao, Sun, Yongcheng, Sheng, Lixia, Xu, Kaihong, Lou, Yanru, Mu, Qitian, Zhang, Yi, Wu, Ningning, Cheng, Jia, Duan, Shiwei |
| author_sort | ouyang, guifang |
| container_issue | 4 |
| container_start_page | 1483 |
| container_title | Journal of International Medical Research |
| container_volume | 47 |
| description | <jats:sec><jats:title>Objectives</jats:title><jats:p> Acute leukemia (AL) is a highly heterogeneous malignant disease caused by hematopoietic cell abnormalities. Our study investigated the potential for immunophenotyping of leukemic cells via flow cytometry and the clinical usefulness of this approach in treatment of AL. </jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p> Bone marrow (BM) specimens were collected to detect antigen expression on hematopoietic cells in pre-treatment samples from patients with AL. In addition, fraction survival curves were calculated using the Kaplan-Meier method to explore the effect of markers on prognosis in AL. </jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p> Expression levels of immunophenotypic markers in patients with acute lymphoblastic leukemia (ALL) were significantly different from those in patients with acute myeloid leukemia (AML). In addition, there was a potential association between the surface marker, cluster of differentiation 2 (CD2), and fraction survival in AML. However, no similar result was found in ALL. Moreover, genetic tests showed greater positive variation of the break point cluster-Abelson tyrosine kinase ( BCR-ABL) fusion gene in samples from patients with ALL than in samples from patients with AML. </jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p> We have shown a rapid and effective flow cytometry method that enables the identification of immunophenotype in AL. Moreover, CD2 may constitute a predictive marker for prognosis in patients with AML. </jats:p></jats:sec> |
| doi_str_mv | 10.1177/0300060518819637 |
| facet_avail | Online, Free |
| finc_class_facet | Biologie, Chemie und Pharmazie |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE3Ny8wMzAwMDYwNTE4ODE5NjM3 |
| imprint | SAGE Publications, 2019 |
| imprint_str_mv | SAGE Publications, 2019 |
| institution | DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1 |
| issn | 0300-0605, 1473-2300 |
| issn_str_mv | 0300-0605, 1473-2300 |
| language | English |
| last_indexed | 2024-03-01T14:04:17.851Z |
| match_str | ouyang2019clinicallyusefulflowcytometryapproachtoidentifyimmunophenotypeinacuteleukemia |
| mega_collection | SAGE Publications (CrossRef) |
| physical | 1483-1492 |
| publishDate | 2019 |
| publishDateSort | 2019 |
| publisher | SAGE Publications |
| record_format | ai |
| recordtype | ai |
| series | Journal of International Medical Research |
| source_id | 49 |
| spelling | Ouyang, Guifang Xu, Zhijuan Jiang, Danjie Zhu, Huiling Wang, Yi Wu, Wenmiao Sun, Yongcheng Sheng, Lixia Xu, Kaihong Lou, Yanru Mu, Qitian Zhang, Yi Wu, Ningning Cheng, Jia Duan, Shiwei 0300-0605 1473-2300 SAGE Publications Biochemistry (medical) Cell Biology Biochemistry General Medicine http://dx.doi.org/10.1177/0300060518819637 <jats:sec><jats:title>Objectives</jats:title><jats:p> Acute leukemia (AL) is a highly heterogeneous malignant disease caused by hematopoietic cell abnormalities. Our study investigated the potential for immunophenotyping of leukemic cells via flow cytometry and the clinical usefulness of this approach in treatment of AL. </jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p> Bone marrow (BM) specimens were collected to detect antigen expression on hematopoietic cells in pre-treatment samples from patients with AL. In addition, fraction survival curves were calculated using the Kaplan-Meier method to explore the effect of markers on prognosis in AL. </jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p> Expression levels of immunophenotypic markers in patients with acute lymphoblastic leukemia (ALL) were significantly different from those in patients with acute myeloid leukemia (AML). In addition, there was a potential association between the surface marker, cluster of differentiation 2 (CD2), and fraction survival in AML. However, no similar result was found in ALL. Moreover, genetic tests showed greater positive variation of the break point cluster-Abelson tyrosine kinase ( BCR-ABL) fusion gene in samples from patients with ALL than in samples from patients with AML. </jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p> We have shown a rapid and effective flow cytometry method that enables the identification of immunophenotype in AL. Moreover, CD2 may constitute a predictive marker for prognosis in patients with AML. </jats:p></jats:sec> Clinically useful flow cytometry approach to identify immunophenotype in acute leukemia Journal of International Medical Research |
| spellingShingle | Ouyang, Guifang, Xu, Zhijuan, Jiang, Danjie, Zhu, Huiling, Wang, Yi, Wu, Wenmiao, Sun, Yongcheng, Sheng, Lixia, Xu, Kaihong, Lou, Yanru, Mu, Qitian, Zhang, Yi, Wu, Ningning, Cheng, Jia, Duan, Shiwei, Journal of International Medical Research, Clinically useful flow cytometry approach to identify immunophenotype in acute leukemia, Biochemistry (medical), Cell Biology, Biochemistry, General Medicine |
| title | Clinically useful flow cytometry approach to identify immunophenotype in acute leukemia |
| title_full | Clinically useful flow cytometry approach to identify immunophenotype in acute leukemia |
| title_fullStr | Clinically useful flow cytometry approach to identify immunophenotype in acute leukemia |
| title_full_unstemmed | Clinically useful flow cytometry approach to identify immunophenotype in acute leukemia |
| title_short | Clinically useful flow cytometry approach to identify immunophenotype in acute leukemia |
| title_sort | clinically useful flow cytometry approach to identify immunophenotype in acute leukemia |
| title_unstemmed | Clinically useful flow cytometry approach to identify immunophenotype in acute leukemia |
| topic | Biochemistry (medical), Cell Biology, Biochemistry, General Medicine |
| url | http://dx.doi.org/10.1177/0300060518819637 |